Akrawinthawong, Krittapoom <br/><br/>
Effectiveness of deferiprone in transfusion-independent beta-thalassemia/HbE patients.  [electronic resource] 

 -  Hematology (Amsterdam, Netherlands)  Mar 2011 
 - 113-22 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1607-8454 
<br/><br/><label>Standard No.: </label>10.1179/102453311X12940641877768  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Cardiovascular Abnormalities--prevention & control<br/>Deferiprone<br/>Echocardiography, Doppler<br/>Female<br/>Ferritins--blood<br/>Follow-Up Studies<br/>Hemoglobin E<br/>Humans<br/>Iron Chelating Agents--adverse effects<br/>Iron Overload--drug therapy<br/>Male<br/>Middle Aged<br/>Oxidative Stress<br/>Pyridones--adverse effects<br/>Transfusion Reaction<br/>Treatment Outcome<br/>Young Adult<br/>beta-Thalassemia--blood